{"podcast":{"title":"Blood Podcast","slug":"blood-podcast-664776","podcast_index_feed_id":664776,"rss_url":"https://feeds.transistor.fm/blood-podcast","website_url":null,"image_url":"https://img.transistorcdn.com/WlMZsA1edpS0qEIavlrh9KLfCFShKE7FTJxZLlZsByw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kY2Q4/YzJhZmMwODBjOWRi/YTNhN2Y1NWJkMzMw/NTBjZi5qcGc.jpg","author":"American Society of Hematology","episode_count":388,"summary":"The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.","last_synced_at":"2026-07-17T04:20:44.828596+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776"},"episode":{"title":"Orca-T for GVHD–free survival and Understanding VEXAS anemia","slug":"orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia","published_at":"2026-06-25T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia","show_page_url":"https://stenobird.com/podcast/blood-podcast-664776","url":"https://share.transistor.fm/s/ae7ba399","audio_url":"https://prfx.byspotify.com/e/media.transistor.fm/ae7ba399/9808c6b1.mp3","summary":"In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Everett Meyer and Olivier Hermine on their latest articles published in volume 147 issue 11 of Blood . Dr. Everett Meyer discusses \" Orca-T vs allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial \" which demonstrated that Orca-T showed superior chronic GVHD–free survival compared to the control arm (78.0% vs 38.4%, P &lt; .001) and lower nonrelapse mortality (3.4% vs 13.2%, P = .03). Dr. Olivier Hermine shares insights from \" VEXAS anemia is a mosaic erythroblastopenia \" which proposes that VEXAS syndrome–associated anemia should be considered as a mosaic erythroblastopenia, in which the severity of anemia is influenced by the quality and quantity of the UBA1 –wild-type compartment.","meta_description":"In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Everett Meyer and Olivier Hermine on their latest articles published in volume 147 is…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1384,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}